SCHEMBL470495

SCHEMBL470495

Bc1ccc(OCC2CCN(C(=O)OC(C)C)CC2)cn1

nearest known ligand 0.66

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 19/20 0.66
CYP4F2 P78329 1/20 0.50
CYP4A11 Q02928 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL384756 0.89 GPR119 (0.66) GPR119CYP4F2CYP4A11
SCHEMBL1092728 0.86 GPR119 (0.66) GPR119CYP4F2CYP4A11
SCHEMBL12064714 0.86 GPR119 (0.59) GPR119
SCHEMBL11956857 0.83 GPR119 (0.84) GPR119
SCHEMBL457366 0.82 GPR119 (0.60) GPR119
SCHEMBL387351 0.81 GPR119 (0.59) GPR119
SCHEMBL387205 0.80 GPR119 (0.77) GPR119CYP4F2CYP4A11
SCHEMBL387260 0.80 GPR119 (0.71) GPR119CYP4F2CYP4A11
SCHEMBL13160668 0.80 GPR119 (0.52) GPR119
SCHEMBL13160671 0.80 GPR119 (0.56) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed
WO-2010103333-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed